NICE Consults On A New Drug To Treat Diabetic Macular Oedema

Tuesday, March 8, 2011

Medical News Today

In draft guidance issued yesterday, NICE has not recommended ranibizumab (Lucentis, Novartis) for treating diabetic macular oedema (DMO).

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

AdGlare Leaderboard